- Home
- ALXO vs SCOR Comparison
ALXO vs SCOR Comparison
Compare ALXO & SCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- SCOR
- Stock Information
- Founded
- ALXO 2015
- SCOR 1999
- Country
- ALXO United States
- SCOR United States
- Employees
- ALXO N/A
- SCOR N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- SCOR Business Services
- Sector
- ALXO Health Care
- SCOR Consumer Discretionary
- Exchange
- ALXO Nasdaq
- SCOR Nasdaq
- Market Cap
- ALXO 28.3M
- SCOR 27.7M
- IPO Year
- ALXO 2020
- SCOR 2007
- Fundamental
- Price
- ALXO $0.42
- SCOR $4.83
- Analyst Decision
- ALXO Strong Buy
- SCOR Buy
- Analyst Count
- ALXO 6
- SCOR 2
- Target Price
- ALXO $3.54
- SCOR $10.75
- AVG Volume (30 Days)
- ALXO 515.3K
- SCOR 9.4K
- Earning Date
- ALXO 05-08-2025
- SCOR 05-06-2025
- Dividend Yield
- ALXO N/A
- SCOR N/A
- EPS Growth
- ALXO N/A
- SCOR N/A
- EPS
- ALXO N/A
- SCOR N/A
- Revenue
- ALXO N/A
- SCOR $354,961,000.00
- Revenue This Year
- ALXO N/A
- SCOR $4.38
- Revenue Next Year
- ALXO N/A
- SCOR $3.97
- P/E Ratio
- ALXO N/A
- SCOR N/A
- Revenue Growth
- ALXO N/A
- SCOR N/A
- 52 Week Low
- ALXO $0.44
- SCOR $4.59
- 52 Week High
- ALXO $17.50
- SCOR $15.69
- Technical
- Relative Strength Index (RSI)
- ALXO 31.14
- SCOR 40.16
- Support Level
- ALXO $0.49
- SCOR $4.86
- Resistance Level
- ALXO $0.55
- SCOR $5.80
- Average True Range (ATR)
- ALXO 0.05
- SCOR 0.42
- MACD
- ALXO 0.00
- SCOR 0.04
- Stochastic Oscillator
- ALXO 4.92
- SCOR 14.29
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About SCOR comScore Inc.
comScore Inc is a United States-based information and analytics company that measures advertising, content, and the consumer audiences of each across media platforms. The platforms it measures include televisions, mobile devices, computers, tablets, CTV devices, and movie theaters. The company generates almost all its revenue from the United States, followed by Europe, Latin America, Canada, and other regions. It provides solutions for the automotive, digital media, financial services, pharmaceutical, retail, technology, travel, and other industries.